Haber M - Search Results

1

Two cases of hypereosinophilia and high-risk acute lymphoblastic leukemia.

Sutton R, Lonergan M, Tapp H, Venn NC, Haber M, Norris MD, O'Brien TA, Alvaro F, Revesz T. Sutton R, et al. Among authors: haber m. Leukemia. 2008 Jul;22(7):1463-5. doi: 10.1038/sj.leu.2405096. Epub 2008 Jan 17. Leukemia. 2008. PMID: 18200036 No abstract available.

2

Reduced drug accumulation as the mechanism of extreme clinical resistance to methotrexate in the human T-cell leukemia xenograft, LALW-2.

Norris MD, Haber M, Kavallaris M, Brian MJ, Lutze LH, White L, Stewart BW. Norris MD, et al. Among authors: haber m. Cancer. 1991 Sep 1;68(5):981-7. doi: 10.1002/1097-0142(19910901)68:5<981::aid-cncr2820680512>3.0.co;2-w. Cancer. 1991. PMID: 1913492

3

Phenotypic and cytogenetic analysis of atypical multidrug resistance in human leukaemic cells selected with methotrexate at high concentration.

Kavallaris M, Haber M, Norris MD, Pittman SM, Reed C, Stewart BW. Kavallaris M, et al. Among authors: haber m. Cancer Lett. 1990 Jun 15;51(3):193-201. doi: 10.1016/0304-3835(90)90102-4. Cancer Lett. 1990. PMID: 1972035

4

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein.

Haber M, Norris MD, Kavallaris M, Bell DR, Davey RA, White L, Stewart BW. Haber M, et al. Cancer Res. 1989 Oct 1;49(19):5281-7. Cancer Res. 1989. PMID: 2569932

5

Atypical multidrug resistance in CCRF-CEM cells selected for high level methotrexate resistance: reactivity to monoclonal antibody C219 in the absence of P-glycoprotein expression.

Norris MD, Haber M, King M, Davey RA. Norris MD, et al. Among authors: haber m. Biochem Biophys Res Commun. 1989 Dec 29;165(3):1435-41. doi: 10.1016/0006-291x(89)92764-2. Biochem Biophys Res Commun. 1989. PMID: 2575383

6

Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant model.

White L, Haber M, Brian MJ, Norris MD, Trickett A, Sosula L, Tiley C, Stewart BW. White L, et al. Among authors: haber m. Cancer. 1989 Jun 1;63(11):2103-10. doi: 10.1002/1097-0142(19890601)63:11<2103::aid-cncr2820631106>3.0.co;2-n. Cancer. 1989. PMID: 2720561

7

Resistance to drugs associated with the multidrug resistance phenotype following selection with high-concentration methotrexate.

Haber M, Reed C, Kavallaris M, Norris MD, Stewart BW. Haber M, et al. J Natl Cancer Inst. 1989 Aug 16;81(16):1250-4. doi: 10.1093/jnci/81.16.1250. J Natl Cancer Inst. 1989. PMID: 2754745

8

Single-strand-specific degradation of DNA during isolation of rat liver nuclei.

Ward EJ, Haber M, Norris MD, Stewart BW. Ward EJ, et al. Among authors: haber m. Biochemistry. 1985 Oct 8;24(21):5803-9. doi: 10.1021/bi00342a018. Biochemistry. 1985. PMID: 3002423

9

Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.

Marshall GM, Kwan E, Haber M, Brisco MJ, Sykes PJ, Morley AA, Toogood I, Waters K, Tauro G, Ekert H, et al. Marshall GM, et al. Among authors: haber m. Leukemia. 1995 Nov;9(11):1847-50. Leukemia. 1995. PMID: 7475273

10

Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers.

Norris MD, Kwan E, Haber M, Marshall GM. Norris MD, et al. Among authors: haber m. Leukemia. 1995 Oct;9(10):1779-82. Leukemia. 1995. PMID: 7564525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

702 results

Search Page

Filters